1 Market Overview
1.1 Non-Invasive Prenatal Testing Product Introduction
1.2 Global Non-Invasive Prenatal Testing Market Size Forecast
1.3 Non-Invasive Prenatal Testing Market Trends & Drivers
1.3.1 Non-Invasive Prenatal Testing Industry Trends
1.3.2 Non-Invasive Prenatal Testing Market Drivers & Opportunity
1.3.3 Non-Invasive Prenatal Testing Market Challenges
1.3.4 Non-Invasive Prenatal Testing Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Non-Invasive Prenatal Testing Players Revenue Ranking (2024)
2.2 Global Non-Invasive Prenatal Testing Revenue by Company (2019-2025)
2.3 Key Companies Non-Invasive Prenatal Testing Manufacturing Base Distribution and Headquarters
2.4 Key Companies Non-Invasive Prenatal Testing Product Offered
2.5 Key Companies Time to Begin Mass Production of Non-Invasive Prenatal Testing
2.6 Non-Invasive Prenatal Testing Market Competitive Analysis
2.6.1 Non-Invasive Prenatal Testing Market Concentration Rate (2019-2025)
2.6.2 Global 5 and 10 Largest Companies by Non-Invasive Prenatal Testing Revenue in 2024
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-Invasive Prenatal Testing as of 2024)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 High & Average Risk
3.1.2 Low Risk
3.2 Global Non-Invasive Prenatal Testing Sales Value by Type
3.2.1 Global Non-Invasive Prenatal Testing Sales Value by Type (2019 VS 2024 VS 2034)
3.2.2 Global Non-Invasive Prenatal Testing Sales Value, by Type (2019-2034)
3.2.3 Global Non-Invasive Prenatal Testing Sales Value, by Type (%) (2019-2034)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 0-12 Weeks
4.1.2 13-24 Weeks
4.1.3 25-36 Weeks
4.2 Global Non-Invasive Prenatal Testing Sales Value by Application
4.2.1 Global Non-Invasive Prenatal Testing Sales Value by Application (2019 VS 2024 VS 2034)
4.2.2 Global Non-Invasive Prenatal Testing Sales Value, by Application (2019-2034)
4.2.3 Global Non-Invasive Prenatal Testing Sales Value, by Application (%) (2019-2034)
5 Segmentation by Region
5.1 Global Non-Invasive Prenatal Testing Sales Value by Region
5.1.1 Global Non-Invasive Prenatal Testing Sales Value by Region: 2019 VS 2024 VS 2034
5.1.2 Global Non-Invasive Prenatal Testing Sales Value by Region (2019-2025)
5.1.3 Global Non-Invasive Prenatal Testing Sales Value by Region (2025-2034)
5.1.4 Global Non-Invasive Prenatal Testing Sales Value by Region (%), (2019-2034)
5.2 North America
5.2.1 North America Non-Invasive Prenatal Testing Sales Value, 2019-2034
5.2.2 North America Non-Invasive Prenatal Testing Sales Value by Country (%), 2024 VS 2034
5.3 Europe
5.3.1 Europe Non-Invasive Prenatal Testing Sales Value, 2019-2034
5.3.2 Europe Non-Invasive Prenatal Testing Sales Value by Country (%), 2024 VS 2034
5.4 Asia Pacific
5.4.1 Asia Pacific Non-Invasive Prenatal Testing Sales Value, 2019-2034
5.4.2 Asia Pacific Non-Invasive Prenatal Testing Sales Value by Country (%), 2024 VS 2034
5.5 South America
5.5.1 South America Non-Invasive Prenatal Testing Sales Value, 2019-2034
5.5.2 South America Non-Invasive Prenatal Testing Sales Value by Country (%), 2024 VS 2034
5.6 Middle East & Africa
5.6.1 Middle East & Africa Non-Invasive Prenatal Testing Sales Value, 2019-2034
5.6.2 Middle East & Africa Non-Invasive Prenatal Testing Sales Value by Country (%), 2024 VS 2034
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Non-Invasive Prenatal Testing Sales Value Growth Trends, 2019 VS 2024 VS 2034
6.2 Key Countries/Regions Non-Invasive Prenatal Testing Sales Value
6.3 United States
6.3.1 United States Non-Invasive Prenatal Testing Sales Value, 2019-2034
6.3.2 United States Non-Invasive Prenatal Testing Sales Value by Type (%), 2024 VS 2034
6.3.3 United States Non-Invasive Prenatal Testing Sales Value by Application, 2024 VS 2034
6.4 Europe
6.4.1 Europe Non-Invasive Prenatal Testing Sales Value, 2019-2034
6.4.2 Europe Non-Invasive Prenatal Testing Sales Value by Type (%), 2024 VS 2034
6.4.3 Europe Non-Invasive Prenatal Testing Sales Value by Application, 2024 VS 2034
6.5 China
6.5.1 China Non-Invasive Prenatal Testing Sales Value, 2019-2034
6.5.2 China Non-Invasive Prenatal Testing Sales Value by Type (%), 2024 VS 2034
6.5.3 China Non-Invasive Prenatal Testing Sales Value by Application, 2024 VS 2034
6.6 Japan
6.6.1 Japan Non-Invasive Prenatal Testing Sales Value, 2019-2034
6.6.2 Japan Non-Invasive Prenatal Testing Sales Value by Type (%), 2024 VS 2034
6.6.3 Japan Non-Invasive Prenatal Testing Sales Value by Application, 2024 VS 2034
6.7 South Korea
6.7.1 South Korea Non-Invasive Prenatal Testing Sales Value, 2019-2034
6.7.2 South Korea Non-Invasive Prenatal Testing Sales Value by Type (%), 2024 VS 2034
6.7.3 South Korea Non-Invasive Prenatal Testing Sales Value by Application, 2024 VS 2034
6.8 Southeast Asia
6.8.1 Southeast Asia Non-Invasive Prenatal Testing Sales Value, 2019-2034
6.8.2 Southeast Asia Non-Invasive Prenatal Testing Sales Value by Type (%), 2024 VS 2034
6.8.3 Southeast Asia Non-Invasive Prenatal Testing Sales Value by Application, 2024 VS 2034
6.9 India
6.9.1 India Non-Invasive Prenatal Testing Sales Value, 2019-2034
6.9.2 India Non-Invasive Prenatal Testing Sales Value by Type (%), 2024 VS 2034
6.9.3 India Non-Invasive Prenatal Testing Sales Value by Application, 2024 VS 2034
7 Company Profiles
7.1 Sequenom
7.1.1 Sequenom Profile
7.1.2 Sequenom Main Business
7.1.3 Sequenom Non-Invasive Prenatal Testing Products, Services and Solutions
7.1.4 Sequenom Non-Invasive Prenatal Testing Revenue (US$ Million) & (2019-2025)
7.1.5 Sequenom Recent Developments
7.2 Roche
7.2.1 Roche Profile
7.2.2 Roche Main Business
7.2.3 Roche Non-Invasive Prenatal Testing Products, Services and Solutions
7.2.4 Roche Non-Invasive Prenatal Testing Revenue (US$ Million) & (2019-2025)
7.2.5 Roche Recent Developments
7.3 Natera
7.3.1 Natera Profile
7.3.2 Natera Main Business
7.3.3 Natera Non-Invasive Prenatal Testing Products, Services and Solutions
7.3.4 Natera Non-Invasive Prenatal Testing Revenue (US$ Million) & (2019-2025)
7.3.5 LabCorp Recent Developments
7.4 LabCorp
7.4.1 LabCorp Profile
7.4.2 LabCorp Main Business
7.4.3 LabCorp Non-Invasive Prenatal Testing Products, Services and Solutions
7.4.4 LabCorp Non-Invasive Prenatal Testing Revenue (US$ Million) & (2019-2025)
7.4.5 LabCorp Recent Developments
7.5 BGI Genomics
7.5.1 BGI Genomics Profile
7.5.2 BGI Genomics Main Business
7.5.3 BGI Genomics Non-Invasive Prenatal Testing Products, Services and Solutions
7.5.4 BGI Genomics Non-Invasive Prenatal Testing Revenue (US$ Million) & (2019-2025)
7.5.5 BGI Genomics Recent Developments
7.6 Quest Diagnostics
7.6.1 Quest Diagnostics Profile
7.6.2 Quest Diagnostics Main Business
7.6.3 Quest Diagnostics Non-Invasive Prenatal Testing Products, Services and Solutions
7.6.4 Quest Diagnostics Non-Invasive Prenatal Testing Revenue (US$ Million) & (2019-2025)
7.6.5 Quest Diagnostics Recent Developments
7.7 Illumina
7.7.1 Illumina Profile
7.7.2 Illumina Main Business
7.7.3 Illumina Non-Invasive Prenatal Testing Products, Services and Solutions
7.7.4 Illumina Non-Invasive Prenatal Testing Revenue (US$ Million) & (2019-2025)
7.7.5 Illumina Recent Developments
7.8 Berry Genomics
7.8.1 Berry Genomics Profile
7.8.2 Berry Genomics Main Business
7.8.3 Berry Genomics Non-Invasive Prenatal Testing Products, Services and Solutions
7.8.4 Berry Genomics Non-Invasive Prenatal Testing Revenue (US$ Million) & (2019-2025)
7.8.5 Berry Genomics Recent Developments
8 Industry Chain Analysis
8.1 Non-Invasive Prenatal Testing Industrial Chain
8.2 Non-Invasive Prenatal Testing Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Non-Invasive Prenatal Testing Sales Model
8.5.2 Sales Channel
8.5.3 Non-Invasive Prenatal Testing Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
